- Country: Macedonia
- Summary: Medicines for Anti Wegf Therapy
- MKT Ref No: 114934221
- Deadline: 20 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 02383/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- S01LA05 AFLIBERCEPT injection solution 40 mg/1 ml 1 glass vial x 100 yl + 1 filter needle/box, quantity 300 vials, SO1LA05 AFLIBERCEPT injection solution 114.3 mg/1 ml 1 vial + 1 filter/box, S01LA06 BROLUCIZUMAB Injection Solution 120 mg/1 ml 1 charged
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicines for Anti Wegf Therapy - Macedonia Tender
The PHI UNIVERSITY EYE DISEASE CLINIC SKOPJE, a Government sector organization in Macedonia, has announced a new tender for Medicines for Anti Wegf Therapy. This tender is published on MacedoniaTenders under MKT Ref No: 114934221 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-20.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
